Dr. Eric K. Singhi discusses the significance of the FDA approval of subcutaneous Opdivo for patients with solid tumors.

Experts shared diagnosis and management strategies for chronic pruritus at the Dermatology Days of Paris 2024 conference.

A novel topical gel, HT-001, has shown potential as a treatment for cutaneous side effects from epidermal growth factor ...

TRAEs of any grade that were more common in the nivolumab-ipilimumab arm than in the chemotherapy arm included pruritus (22% and 5%), hypothyroidism (16% and 0%), rash (10% and 8%), alanine ...

The combination of brain radiotherapy and chemoimmunotherapy “resulted in promising intracranial and systemic anti-tumor activity, with a manageable safety profile,” researchers wrote.

The Food and Drug Administration (FDA) has accepted for Priority Review the Biologics License Application (BLA) for datopotamab deruxtecan (Dato-DXd) for the treatment of adults with locally advanced ...

Reaching more mUM patients globally with KIMMTRAK (tebentafusp) in 2025 through additional launches and increased community penetrationEnrolling ...

The Food and Drug Administration has approved Unloxcyt (cosibelimab-ipdl) for advanced cutaneous squamous cell carcinoma.

Novocure today reported preliminary unaudited financial and operational results for the quarter and full year ended December 31, 2024. Novocure is a global oncology company working to extend survival ...

Patch testing, if performed, was not reported. In addition, 0.7% reported pruritus, and 0.5% reported an erythematous rash. [19] Several patients with ACD from a buprenorphine TTS have also been ...

Lowers body temperature: While humans cool off by sweating or turning on the A/C, cats can cool down by licking. In a 2018 ...